CATAPULT SPORTS LIMITED (CAT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CAT

CAT - CATAPULT SPORTS LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: March
GICS Industry Group : Technology Hardware & Equipment
Debt/EBITDA: 0.32
Index: ASX300 | ALL-ORDS | ALL-TECH

Catapult Group develops and sells wearable sensors to monitor and analyse athletic performance, including fitness and skill levels, injury risks and rehabilitation assistance. It listed on the ASX in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.69

03 Jun
2026

-0.260

OPEN

$3.81

-6.58%

HIGH

$3.88

1,430,392

LOW

$3.63

TARGET
$5.134 39.1% upside
OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . AYA . BB1 . BRN . CBL . CGS . CMP . COH . CSX . CTE . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RAP . RMD . SHG . SOM . TRJ . UBI .
FNARENA'S MARKET CONSENSUS FORECASTS
CAT: 1
Title FY27
Forecast		 FY28
Forecast
EPS (cps) - 8.4 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx-13.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx213.0 M
Book Value Per Share xxxxxxxxxxxxxxx101.6
Net Operating Cash Flow xxxxxxxxxxxxxxx57.3 M
Net Profit Margin xxxxxxxxxxxxxxx-17.03 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx-16.41 %
Return on Invested Capital xxxxxxxxxxxxxxx-15.73 %
Return on Assets xxxxxxxxxxxxxxx-9.79 %
Return on Equity xxxxxxxxxxxxxxx-16.41 %
Return on Total Capital xxxxxxxxxxxxxxx-14.18 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx36.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx2 M
Long Term Debt xxxxxxxxxxxxxxx6 M
Total Debt xxxxxxxxxxxxxxx8 M
Goodwill - Gross xxxxxxxxxxxxxxx164 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx78 M
Price To Book Value xxxxxxxxxxxxxxx3.17

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx56.7 M
Capex % of Sales xxxxxxxxxxxxxxx26.60 %
Cost of Goods Sold xxxxxxxxxxxxxxx214 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx32 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

21/05/2026

1

Buy

$3.97

7.59%

Ord Minnett describes Catapult Sports' FY26 result as impressive, with revenue, annual contract value (ACV) and earnings all exceeding expectations. Strong growth in professional teams and higher-value multi-solution customers are noted.

Commentary also points to balanced growth from both new customer wins and upselling existing clients, with organic team additions remaining robust despite recent acquisitions.

The broker sees an accelerating path to profitability as operating leverage and higher-margin product adoption drive margin expansion.

Despite strong growth and improving profitability, the broker believes Catapult continues to trade at an attractive valuation relative to software peers. Buy rating retained. Target price lowered to $3.97 from $4.16.

FORECAST
Ord Minnett forecasts a full year FY27 dividend of 0.00 cents and EPS of minus -14.96 cents.
Ord Minnett forecasts a full year FY28 dividend of 0.00 cents and EPS of 0.00 cents.

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

25/05/2026

1

Buy

$8.00

116.80%

Canaccord Genuity retains a Buy rating for Catapult Sports with a $8.00 target price following a "strong" FY26 financial result.

Annualised contract value grew 28% to US$133.8m, driving a 19% increase in total revenue to US$141m alongside expanding gross margins.

Operating earnings rose 67% to US$25m, reflecting strong operating leverage and an accelerated path toward the 30% long-term margin target.

The business remains self-funding with over US$53m in cash reserves and zero debt, providing material optionality for strategic acquisitions to expand the product suite.

Forward operating earnings estimates are upgraded by 11% to 14% across the medium term to reflect the sustained organic growth trajectory and resilient pro-team retention rates, the broker notes.
Access Extra Coverage Research History >

CAT STOCK CHART

FNArena News on CAT

1
Rudi’s View: Tech Is Back (Ahead Of Tax Loss Selling)

Jun 03 2026 - Rudi's View
2
FNArena Corporate Results Monitor – 01-06-2026

Jun 01 2026 - Australia
3
Australian Broker Call *Extra* Edition – May 25, 2026

May 25 2026 - Daily Market Reports
4
Next Week At A Glance – 25-29 May 2026

May 22 2026 - Weekly Reports
5
Rudi’s View: Best Buys & Conviction Calls

Apr 23 2026 - Rudi's View

Latest Medical Equipment & Devices News

1
Treasure Chest: Pro Medicus

11:15 AM - Treasure Chest
2
Cochlear’s Shock Downgrade Raises Concerns

Apr 23 2026 - Australia
3
GLP-1s Drive Strong Quarter For ResMed

Feb 02 2026 - Australia
4
ImpediMed Ready To Scale Up

Dec 16 2025 - Small Caps
5
Fisher & Paykel Healthcare’s Superior Profile

Dec 02 2025 - Australia
6
4DMedical Poised For A Recovery

Nov 25 2025 - Technicals
7
Treasure Chest: Pro Medicus

Nov 12 2025 - Treasure Chest
8
Tariff Uncertainty Negates ResMed’s Q1 Positives

Nov 05 2025 - Australia
9
Acquisition Loads Up Catapult

Oct 20 2025 - Small Caps
10
Cochlear’s Future In Nexa’s Hands

Aug 19 2025 - Australia